Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
AssigneeThe Texas A&M University System
InventorsJorge A. Piedrahita, Chang-Kyu Lee, Regina Weaks, Fuller Bazer
Life of this patent
Estimating the term…
Abstract
Provided are methods and compositions for increasing the efficiency of nuclear transfer using apoptosis inhibitors, and for the production of transgenic and non-transgenic mammals from cultured cells or cell lines. Methods for cloning mammals, and for producing transgenic and chimeric mammalian tissues and mammals, and chimeric cell lines are also provided.
Claims60
A method of increasing the number of nuclear transfer competent cells within a mammalian cell population, comprising culturing said cell population in serum starvation media containing an amount of at least a first apoptosis inhibitor effective to increase the number of cells at the G0/G1 stage of the cell cycle within said cell population.
A method of growing fetal or embryonic fibroblasts or primordial germ cells, comprising growing a cell culture comprising fetal or embryonic fibroblasts or primordial germ cells on an effective density of feeder cells and in a biologically effective serum starvation medium comprising an amount of at least a first apoptosis inhibitor effective to increase the number of cells at the G0/G1 stage of the cell cycle when said cell culture is maintained for a time sufficient to obtain undifferentiated fetal or embryonic fibroblasts or primordial germ cells.
A method of nuclear transfer, comprising culturing a mammalian cell population containing cells at the G0/G1 stage of the cell cycle in serum starvation media comprising an amount of at least a first apopotosis inhibitor effective to increase the proportion of viable G0/G1 cells in said cell population;
- and fusing at least a first viable G0/G1 cells with an enucleated mammalian ovum.
A method of preparing mammalian cells at the G0/G1 stage of the cell cycle that contain a selected DNA segment, comprising:
- a) culturing a mammalian cell population containing cells at the G0/G1 stage of the cell cycle in serum starvation media comprising an amount of at least a first apoptosis inhibitor effective to increase the proportion of viable G0/G1 cells in said cell population;
- and
- b) introducing said DNA segment into the viable G0/G1 cells in said cell population.
A method of nuclear transfer, comprising culturing a cell population containing bovine or porcine fetal or embryonic fibroblasts or primordial germ cells at the G0/G1 stage of the cell cycle in serum starvation media comprising an amount of at least a first apoptosis inhibitor effective to increase the proportion of viable G0/G1 cells in said cell population;
- and fusing at least a first viable G0/G1 cell from the cultured cell population with an enucleated bovine or porcine ovum, thereby achieving nuclear transfer.
A method of nuclear transfer, comprising culturing a mammalian cell population containing cells at the G0/G1 stage of the cell cycle in serum starvation media comprising an amount of the apoptosis inhibitor α2-macroglobulin (MAC) effective to increase the proportion of viable G0/G1 cells in said cell population when present substantially throughout the culture of said cell population;
- and fusing at least a first viable G0/G1 cell from the cultured cell population with an enucleated mammalian ovum, thereby achieving nuclear transfer.
A method of nuclear transfer, comprising culturing a mammalian cell population containing cells at the G0/G1 stage of the cell cycle in serum starvation media comprising an apoptosis inhibitor selected from the group consisting of N-acetylcysteine (NAC), butylated hydroxyanisole (BHA), cimetidine (CIM), N-t-butyl-α-phenylnitrone (BPN) and glutathione (GSH) in an amount effective to increase the proportion of viable G0/G1 cells in said cell population;
- and fusing at least a first viable G0/G1 cell from the cultured cell population with an enucleated mammalian ovum, thereby achieving nuclear transfer.
A method of nuclear transfer, comprising culturing a mammalian cell population containing cells at the G0/G1 stage of the cell cycle in serum starvation media comprising an amount of the apoptosis inhibitor N-acetylcysteine (NAC) effective to increase the proportion of viable G0/G1 cells in said cell population when present at the initial stages of the culture of said cell population;
- and fusing at least a first viable G0/G1 cell from the cultured cell population with an enucleated mammalian ovum, thereby achieving nuclear transfer.
A method of nuclear transfer, comprising culturing a mammalian cell population containing cells at the G0/G1 stage of the cell cycle in serum starvation media comprising at least a first serine protease apoptosis inhibitor and at least a second antioxidant apoptosis inhibitor in an amount effective to increase the proportion of viable G0/G1 cells in said cell population;
- and fusing at least a first viable G0/G1 cell from the cultured cell population with an enucleated mammalian ovum, thereby achieving nuclear transfer.
A method of nuclear transfer, comprising culturing a mammalian cell population containing cells at the G0/G1 stage of the cell cycle in serum starvation media comprising an amount of at least a first serine protease apoptosis inhibitor other than a2-macroglobulin effective to increase the proportion of viable G0/G1 cells in said cell population;
- and fusing at least a first viable G0/G1 cell with an enucleated mammalian ovum.
A method of nuclear transfer, comprising culturing a mammalian cell population containing cells at the G0/G1 stage of the cell cycle in serum starvation media comprising an amount of at least a first antioxidant apoptosis inhibitor other than thioredoxin in an amount effective to increase the proportion of viable G0/G1 cells in said cell population;
- and fusing at least a first viable G0/G1 cell with an enucleated mammalian ovum.
A method of nuclear transfer, comprising culturing a mammalian cell population containing cells at the G0/G1 stage of the cell cycle in serum starvation media comprising an amount of at least a first apoptosis inhibitor other than α2-macroglobulin, thioredoxin or uteroferrin in an amount effective to increase the proportion of viable G0/G1 cells in said cell population;
- and fusing at least a first viable G0/G1 cell with an enucleated mammalian ovum.
A method of cloning a mammal from somatic or primordial germ cells, comprising:
- (a) culturing a population of mammalian somatic or primordial germ cells containing cells at the G0/G1 stage of the cell cycle in serum starvation media comprising an effective amount of at least a first apoptosis inhibitor for a period of time suitable to increase the proportion of viable G0/G1 cells in said population;
- and
- (b) generating a viable cloned mammal from at least a first of said viable G0/G1 cells.
A method of producing a transgenic mammal, comprising:
- (a) culturing a population of mammalian somatic or primordial germ cells containing cells at the G0/G1 stage of the cell cycle in serum starvation media comprising an effective amount of at least a first apoptosis inhibitor for a period of time suitable to increase the proportion of viable G0/G1 cells in said population;
- (b) introducing a selected DNA segment into viable G0/G1 cells of said cell population to produce viable transgenic G0/G1 cells;
- and
- (c) generating a transgenic mammal from at least a first of said viable transgenic G0/G1 cells.
A method of producing a mammalian cell line from a somatic mammalian cell, comprising:
- (a) culturing a population of said somatic cells containing cells at the G0/G1 stage of the cell cycle in serum starvation media comprising an effective amount of at least a first apoptosis inhibitor for a period oftime suitable to increase the proportion of viable G0/G1 somatic cells in said population;
- (b) fusing at least a first of said viable G0/G1 somatic cells with an enucleated mammalian ovum;
- (c) culturing the fused cell/ovum in embryo media for a period of time effective to reach the morula/blastocyst stage of development;
- and
- (d) culturing the morula/blastocyst in complete media for period of time effective to allow the development of a mammalian cell line.
Dependencies are inferred from the claim text.